Neurokinin 1 receptors regulate morphine-induced endocytosis and desensitization of mu-opioid receptors in CNS neurons.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Y Joy YuMark Von Zastrow

Abstract

mu-Opioid receptors (MORs) are G-protein-coupled receptors (GPCRs) that mediate the physiological effects of endogenous opioid neuropeptides and opiate drugs such as morphine. MORs are coexpressed with neurokinin 1 receptors (NK1Rs) in several regions of the CNS that control opioid dependence and reward. NK1R activation affects opioid reward specifically, however, and the cellular basis for this specificity is unknown. We found that ligand-induced activation of NK1Rs produces a cell-autonomous and nonreciprocal inhibition of MOR endocytosis induced by diverse opioids. Studies using epitope-tagged receptors expressed in cultured striatal neurons and a neuroblastoma cell model indicated that this heterologous regulation is mediated by NK1R-dependent sequestration of arrestins on endosome membranes. First, endocytic inhibition mediated by wild-type NK1Rs was overcome in cells overexpressing beta-arrestin2, a major arrestin isoform expressed in striatum. Second, NK1R activation promoted sequestration of beta-arrestin2 on endosomes, whereas MOR activation did not. Third, heterologous inhibition of MOR endocytosis was prevented by mutational disruption of beta-arrestin2 sequestration by NK1Rs. NK1R-mediated regulation of MOR traffick...Continue Reading

References

Jun 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·A Tempel, R S Zukin
Jan 1, 1971·Acta Physiologica Scandinavica. Supplementum·U Ungerstedt
Oct 14, 1983·European Journal of Pharmacology·H J CheesemanG Henderson
Jan 1, 1984·Annual Review of Neuroscience·D E Redmond, J H Krystal
Jan 1, 1994·Brain Research Bulletin·E J NestlerG K Aghajanian
Aug 9, 1996·The Journal of Biological Chemistry·D E KeithM von Zastrow
Dec 1, 1996·Neuroscience·E F GradyN W Bunnett
Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·J ZhangM G Caron
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·J L Whistler, M von Zastrow
Apr 25, 2000·The Journal of Biological Chemistry·S J Mundell, J L Benovic
Apr 3, 2001·Nature Reviews. Neuroscience·M Bouvier
Dec 26, 2001·Molecular Pharmacology·T BushellR J Miller
Mar 7, 2002·Proceedings of the National Academy of Sciences of the United States of America·Fabien SchmidlinEileen F Grady
Jun 13, 2003·Biomedical Engineering Online·Thomas A PologrutoKarel Svoboda
Oct 9, 2003·The Journal of Biological Chemistry·Manuela PfeifferStefan Schulz
Aug 27, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Helena Haberstock-DebicMark von Zastrow
Apr 22, 2006·The Journal of Comparative Neurology·Jean-François PoulinGuy Drolet
Dec 13, 2006·Molecular Cell·Robert J LefkowitzErin J Whalen
Jul 10, 2008·Molecular Pharmacology·Seksiri ArttamangkulJohn T Williams

❮ Previous
Next ❯

Citations

Jan 17, 2013·Pharmacological Reviews·John T WilliamsMacdonald J Christie
Nov 5, 2011·Cancer Research·Rajarshi SenguptaJoshua B Rubin
Dec 22, 2012·Journal of Molecular Endocrinology·Roger López-BellidoRaquel E Rodríguez
Jun 23, 2011·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Pamela LyonJohn Quintner
Apr 1, 2014·Current Opinion in Cell Biology·Roshanak Irannejad, Mark von Zastrow
Dec 17, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jian LuZaijie Jim Wang
Oct 9, 2012·Neuron·Mark von Zastrow, John T Williams
Dec 11, 2007·Current Opinion in Neurobiology·Lene Martini, Jennifer L Whistler
Nov 22, 2015·Neuron·Pierangelo GeppettiNigel W Bunnett
Nov 13, 2009·Annals of the New York Academy of Sciences·Richard L HaugerFrank M Dautzenberg
May 7, 2013·Pain·Clas Linnman
May 14, 2011·British Journal of Pharmacology·Vu C Dang, MacDonald J Christie
Jan 3, 2014·Physiological Reviews·Martin S SteinhoffNigel W Bunnett
Jul 20, 2014·The Journal of Pharmacology and Experimental Therapeutics·Jesse R Schank
Jul 4, 2015·American Journal of Physiology. Gastrointestinal and Liver Physiology·Daniel P PooleNigel W Bunnett

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amygdala and Midbrain Dopamine

The midbrain dopamine system is widely studied for its involvement in emotional and motivational behavior. Some of these neurons receive information from the amygdala and project throughout the cortex. When the circuit and transmission of dopamine is disrupted symptoms may present. Here is the latest research on the amygdala and midbrain dopamine.

Amygdala: Sensory Processes

Amygdalae, nuclei clusters located in the temporal lobe of the brain, play a role in memory, emotional responses, and decision-making. Here is the latest research on sensory processes in the amygdala.

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.